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PAX6 does not regulate Nfia and 
Nfib expression during neocortical 
development
Jens Bunt1, Jonathan W. C. Lim1, Lu Zhao1, Sharon Mason1 & Linda J. Richards1,2
The Nuclear factor I (NFI) family of transcription factors regulates proliferation and differentiation 
throughout the developing central nervous system. In the developing telencephalon of humans 
and mice, reduced Nfi expression is associated with agenesis of the corpus callosum and other 
neurodevelopmental defects. Currently, little is known about how Nfi expression is regulated during 
early telencephalic development. PAX6, a transcription factor important for telencephalic development, 
has been proposed as an upstream regulator of Nfi expression in the neocortex. Here we demonstrate 
that, in the developing neocortex of mice, NFIA and NFIB are endogenously expressed in gradients 
with high caudo-medial to low rostro-lateral expression and are most highly expressed in the cortical 
plate. We found that this expression pattern deviates from that of PAX6, suggesting that PAX6 
does not drive Nfi expression. This is supported by in vitro reporter assays showing that PAX6 over-
expression does not regulate Nfi promoter activity. Similarly, we also found that in the Pax6 Small 
Eye mutant, no changes in Nfi mRNA or protein expression are observed in the neocortical ventricular 
zone where PAX6 and the NFIs are expressed. Together these data demonstrate that in mice, PAX6 
is not a transcriptional activator of Nfi expression during neocortical development.
Transcriptional regulatory networks are fundamental to the development of distinct cellular populations 
throughout embryogenesis. These networks consist of interconnected and independent transcriptional 
regulatory cascades that are conventionally inferred from gene expression and phenotypic analyses of 
loss-of-function animal models. Identifying these regulatory pathways during neurodevelopment may 
implicate novel genes in neurodevelopmental disorders, or determine if similar disorders are the result 
of interconnected or distinct causes. In the developing telencephalon, the Nuclear factor I (NFI) family 
of transcription factors forms part of such an undefined network, with the majority of its regulatory 
components currently unknown. In mice the NFI transcription factors are expressed from embryonic 
day (E)12 within the dorsal telencephalon1, and function to regulate the proliferation and differentiation 
of neural progenitor cells2–8. Knockout mice for Nfia, Nfib or Nfix display similar forebrain phenotypes2–8. 
These mice are characterized by delayed glial differentiation, consequently resulting in malformations of 
the corpus callosum and hippocampus2–8. In humans, haploinsufficiency for NFI has been similarly asso-
ciated with agenesis of the corpus callosum and other neurodevelopmental disorders9–16. Thus, precise 
regulation of Nfi expression is required for normal forebrain development in both humans and mice.
The transcription factor PAX6 has been implicated as a potential transcriptional activator of Nfia 
and Nfib expression in the developing neocortex17. PAX6 expression precedes both NFIA and NFIB, 
and is expressed within the proliferative ventricular zone (VZ) of the dorsal telencephalon throughout 
embryonic development1,18. The function of PAX6 has been examined in a number of different Pax6 
loss-of-function mouse models, most notably the Pax6 Small Eye (Pax6Sey) mutant strain19–21. This model 
expresses a truncated PAX6 protein that lacks the homeobox DNA-binding domain due to a mutation 
that introduces a premature stop codon20. Gene expression array analyses comparing Pax6Sey/Sey mutant 
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and wildtype neocortices have identified potential downstream candidates regulated by PAX6 during 
prenatal development. In the Pax6Sey/Sey neocortex, expression of both Nfia and Nfib are reduced at E12, 
with Nfia expression similarly reduced at E1517. As Pax6 overexpression in cultured E13 cortical cells cor-
respondingly increased Nfia expression, Nfia appears to be a bona fide transcriptional target of PAX617. 
In this paper, we investigated the hypothesis that PAX6 functions as a transcriptional activator of Nfia 
and Nfib (hereafter referred to as Nfi) within the developing neocortex.
Results
NFI expression opposes the gradient of PAX6 expression during neocortical development. It 
has previously been shown that PAX6 expression in the developing neocortex is limited to the VZ, 
where it is expressed in a high rostro-lateral to low caudo-medial gradient22. We reasoned that if PAX6 
transcriptionally activates Nfia or Nfib expression, the expression patterns of these transcription factors 
would resemble each other. To test this, we analyzed NFI protein expression across the neocortex of 
wildtype C57Bl/6J mice at E13 and E15. In contrast to PAX6 expression, we observed that in coronal 
sections at E13, both NFIA and NFIB are expressed in high medial to low lateral gradients (Fig.  1A). 
Similarly, analyses of sagittal sections at this age show that both NFIA and NFIB are expressed higher 
caudally and lower rostrally (Fig. 1B). At E15, the graded expression of NFIA and NFIB is sustained in 
the medial-to-lateral axis (Fig. 1C), but not in the rostral-to-caudal axis, where NFI protein expression 
was now more evenly distributed (Fig. 1D). The graded expression of Nfia and Nfib in the sagittal plane 
was confirmed at the mRNA level at E11.5 and E13.5 by examining in situ hybridization data available 
from the Allen Brain Atlas (Supplementary Figure 1)23.
Similarly, we note that the NFI transcription factors were more broadly expressed across the cortical 
laminae as compared to PAX6 expression. In line with our previous characterization of NFI expression 
in the developing forebrain1, we observed that both NFIA and NFIB are most highly expressed within 
the cortical plate of the neocortex (Fig.  1 and S1), where PAX6 is not expressed18. Thus, in mice, the 
graded expression pattern of NFIA and NFIB across the wildtype neocortex does not resemble that of 
PAX6 expression.
To determine whether NFI expression correlates with PAX6 expression during human neocortical 
development, we analyzed publically available mRNA expression data obtained from neocortical regions 
at 12 and 13 weeks post-conception24 (Fig. 2A), which correspond to our E13 and E15 analyses in mice25. 
At both ages, NFIA and NFIB expression levels in the neocortical areas showed no significant correlation 
with PAX6 expression levels in the neocortex (Fig. 2A), whereas SFRP1 and EOMES showed significant 
correlation as reported previously in mice17,26,27. Thus, endogenous expression of NFIA and NFIB do not 
appear to be positively correlated with PAX6 expression in the developing neocortex of both mice and 
humans.
Differential expression of Nfia and Nfib in Pax6 mouse models. We next investigated the 
reproducibility of reduced Nfi expression previously reported in microarray analyses of the Pax6Sey/Sey 
mutant17. Using validated independent primer sets for quantitative PCR28, we analyzed Nfi mRNA levels 
in microdissected dorsolateral cortex/neocortex of E13 Pax6Sey/Sey and wildtype embryos. We observed 
reduced Nfia and Nfib expression in the Pax6Sey/Sey neocortex (-3.2 and -4.3 fold, respectively when com-
pared within litters). These reductions did not achieve statistical significance when litters were pooled 
due to the large variation between litters (p = 0.32 and p = 0.22, respectively; one-way ANOVA). To 
determine if the down-regulation of Nfi expression observed in the Pax6Sey/Sey neocortex is reproducible 
in microarray analyses, we analyzed independent Pax6Sey/Sey expression datasets of E12.5 neocortex27, 
E14 rostral cortex29 and E14.5 neocortex30 (Fig.  2B; yellow). In line with the observations of Holm et 
al.17, Nfia expression was significantly reduced at all ages. In contrast, Nfib expression was significantly 
reduced only in the E12.5 dataset.
As the reduction of Nfi expression may be specific to the Pax6Sey mouse model and its phenotype, we 
also analyzed available expression data from other Pax6 mutants, namely the D6-PAX627, Pax6Leca2 and 
Pax6Leca4 31,32 mouse mutants. A significant increase in Nfib expression was observed in E12.5 neocortex 
for the D6-PAX6 mouse model that over-expresses wildtype PAX6 (Fig. 2B; red, Sansom and colleagues 
also reported increased Nfia expression but no raw data is available to validate this)27. In the Pax6Leca2 
and Pax6Leca4 mouse models, no reduction in Nfia or Nfib expression was detected in E14 rostral cortex 
in contrast to reduced Nfia expression in the Pax6Sey rostral cortex collected and analyzed within the 
same experiment (Fig. 2B; orange)29. These mice differ from the Pax6Sey mice as they both carry single 
missense mutations that result in the expression of functional PAX6 protein with reduced DNA binding 
capability31,32. Thus the mis-regulation of Nfi expression is not consistently observed in other Pax6 mouse 
models.
Mutation of PAX6 does not alter radial glial expression of NFI. Our analyses thus far suggest 
that PAX6 is unlikely to function as a direct transcriptional activator of Nfi expression in the develop-
ing neocortex. To further test this hypothesis, we used an in vitro reporter assay to determine if PAX6 
over-expression regulates Nfi promoter activity. We transfected mouse Nfia or Nfib promoter-driven 
luciferase constructs (pNfia-LUC or pNfib-LUC), or a control reporter plasmid into the NE-4C (mouse 
neuroepithelial cell line) and U251 MG (human glioma cell line) cell lines. No change in Nfi promoter 
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activities were observed when these cells were co-transfected with a PAX6 overexpression construct 
(pCAGIG-PAX6) as compared to an empty control vector (Fig. 2C).
Nevertheless, if PAX6 autonomously regulates Nfi expression in vivo, this regulation would likely be 
limited to the VZ where PAX6 and the NFIs are expressed22. To test this, we first determined whether 
PAX6 and NFIB are co-expressed within the same cells in the neocortical VZ. Using a knock-in reporter 
gene for NFIB substituted into the deleted exon of the Nfib knockout mice3,7,33, we observed co-expression 
of the β -galactosidase reporter gene and PAX6 in the radial glial cells of E13 heterozygous Nfib knock-
out mice, as has been reported at E18.5 (Fig. 2D)3,7,33. In keeping with our analyses of endogenous NFI 
expression in wildtype mice (Fig.  1), PAX6 expression across the neocortical VZ negatively correlated 
Figure 1. NFIA and NFIB are expressed in a high caudo-medial to low rostro-lateral gradient in 
the developing neocortex. Coronal and sagittal sections of E13 (A and B) and E15 (C and D) C57Bl/6J 
wildtype brains were analyzed for NFI protein expression in the medial-to-lateral and rostral-to-caudal axes 
respectively. NFIA and NFIB were expressed in a high medial to low lateral gradient at both ages (A and C) 
and in a high caudal to low rostral gradient at E13, but not at E15 (B and D). The developing cortical plate 
(CP) showed highest expression across the cortical laminae, with intermediate expression in the ventricular 
zone (VZ). For coronal sections, A’ and C’ represent medial insets and A” and C” represent lateral insets. 
For sagittal sections, B’ and D’ represent caudal insets and B” and D” represent rostral insets. Scale bars 
represent 500 μ m in low-powered magnifications and 100 μ m (A and C) or 20 μ m (B and D) in high-
powered magnification panels. SVZ = subventricular zone; IZ = intermediate zone; D = dorsal; L = lateral; 
R = rostral.
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Figure 2. NFI and PAX6 expression are not correlated in the developing neocortex and PAX6 does 
not activate Nfi promoter activity in vitro. (A). Correlation of PAX6 mRNA expression (black) with 
NFIA, NFIB, EOMES or SFRP1 mRNA expression (red) at 12 (upper panels) and 13 (lower panels) weeks 
post-conception in the human neocortex24. (B). Relative expression of Nfia and Nfib in the Pax6 loss-of-
function mouse models Pax6Sey (SEY), Pax6Leca2 (LECA2) and Pax6Leca4 (LECA4) and the transgenic PAX6 
over-expression model Dach1-PAX6 (D6-PAX6) from published expression datasets27,29,30,34, normalized to 
wildtype control (100%; dashed line) for comparison between datasets. All datasets represent rostral cortex/
neocortex, with the exception of the first set (blue) that was generated from the PAX6-positive fraction 
only34. Statistical significance was determined using one-way ANOVA for genotypes with n = 3 or more. NA 
= raw data not available from original dataset, *1 = reported significant in original dataset, *2 = p < 0.05 by 
one-way ANOVA, NS = non-significant (one-way ANOVA). (C). Relative luciferase activity of NE-4C and 
U251 MG cells transfected with the pGL4.23 luciferase construct driven by the mouse Nfia or Nfib promoter 
(pNfia-LUC and pNfib-LUC respectively) or its endogenous minimal promoter. PAX6 and pCAGIG 
denote cells co-transfected with the PAX6-over-expression or empty control vectors. Luciferase activity 
was determined 48 hours after transfection and normalized to Renilla luciferase that was co-trasfected 
as an internal control. pNfia-LUC with pCAGIG was scaled to ‘1’ and all other conditions were then 
normalized to this to determine relative luciferase activity. No statistical significance was observed between 
pCAGIG and PAX6 for all experimental conditions (n = 3, figure depicts a representative sample with three 
technical replicates). (D-F). Representative immunofluorescence images of coronal (D and F) and sagittal 
(E) sections of E13 Nfib heterozygous brains stained for PAX6 and the β -galactoside reporter knocked into 
the Nfib locus. The boxed region in the low-magnification panel in (D) represents subsequent panels with 
high-powered magnification showing PAX6 and β -galactoside co-expression. Scale bars represent 100 μ m 
(low-powered) and 20 μ m (high-powered magnification) in D, 200 μ m (E) or 100 μ m (F). D = dorsal; R = 
rostral; L = lateral.
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with β -galactosidase expression in Nfib heterozygous mice when observed in both the sagittal (Fig. 2E) 
and coronal (Fig. 2F) planes.
To investigate whether Nfi expression is specifically mis-regulated in the radial glial cells of Pax6Sey 
mice, we analyzed Nfi expression using previously published data obtained from flow cytometry-sorted 
populations of PAX6-positive cells. Price and colleagues generated this data by crossing the Pax6Sey mice 
to the DTy54 reporter mouse line with GFP expression in PAX6-positive cells34. Analyses of Nfia and 
Nfib expression in GFP-positive cells obtained from E12.5 Pax6Sey/Sey mutant and wildtype neocortices 
revealed no difference in Nfi expression (Fig. 2B; blue). Thus, the reduction of Nfi expression observed 
in microarray analyses of Pax6Sey/Sey mutants cannot be justified by the mis-regulation of Nfi expression 
in radial glial cells.
To validate this at the protein level, we quantified NFIA and NFIB protein expression in horizontal 
sections of E13 Pax6Sey/Sey mutant and wildtype brains (Fig. 3A,B). For each section analyzed, the neocor-
tex from the ventricular to pial surfaces were divided into 20 equally spaced bins, with strict precautions 
taken to account for variability between sections (see Methods for a full description). These analyses 
were independently repeated at three different regions along the rostral to caudal axis to account for the 
graded expression observed in this axis. In all three analyses, we observed no significant reduction in NFI 
expression in the bins that represent the VZ where PAX6 is expressed. On the contrary, slight changes 
in NFIA expression were observed in the bins that corresponded to the cortical plate where PAX6 is not 
expressed but the NFI transcription factors are strongly expressed.
We conducted similar analyses on E15 Pax6Sey/Sey mutant brains sectioned coronally, and inde-
pendently analyzed matched rostral and caudal sections. Again, no significant decrease in NFI expres-
sion was detected in bins that correspond to the VZ (Fig. 3C,D). In the bins that represented the cortical 
plate, we observed that peak NFIA expression shifted dorsally towards the pial surface in the Pax6Sey/Sey 
mutants as compared to wildtype controls. Nevertheless, as the VZ cells that express PAX6 and the NFI 
transcription factors showed no mis-regulation of NFI expression, PAX6 does not function to activate 
Nfi transcription in radial glial cells of the developing neocortex.
Discussion
The identification of transcriptional regulatory cascades is integral to determining whether similar neu-
rodevelopmental disorders are the result of interconnected or distinct causes. In the developing telenceph-
alon, the NFI and PAX6 transcription factors are involved in proliferation and neurogenesis2–8,27,29,34–37. 
Haploinsufficiency of these transcription factors in humans is similarly implicated with agenesis of the 
corpus callosum9–16,38,39. As PAX6 expression precedes NFI expression in the neocortex1,18 and deletion of 
Pax6 results in reduced Nfi expression in the Pax6Sey/Sey neocortex17, PAX6 was hypothesized to directly 
regulate Nfi expression during neocortical development.
In the current study, we present several lines of evidence that contradict this hypothesis. Whilst 
gene expression analyses of Pax6Sey/Sey neocortex validate the reduction of Nfi expression reported pre-
viously17,27,29,30, our immunohistochemistry analyses to investigate NFI expression, and the inconsist-
encies in Nfi expression observed amongst the Pax6 mouse models suggest possible discrepancies27,32. 
Significantly, we report from our analyses as well as the data published by Price and colleagues34 that 
Nfia and Nfib are not mis-regulated at the mRNA or protein levels in the Pax6Sey/Sey VZ where PAX6 
may autonomously regulate these transcription factors. This suggests that, despite the reduction of Nfi 
expression observed in the Pax6Sey/Sey neocortex, PAX6 is not a direct transcriptional activator of Nfi 
expression in the developing neocortex.
Interestingly, we observed increased NFIA expression in the cortical plate of Pax6Sey/Sey mutants 
(Fig. 3C). As PAX6 is not expressed in the developing cortical plate, PAX6 is unlikely to transcriptionally 
activate Nfia expression in this region. Rather, it is likely that the previously described precocious neu-
rogenesis in the Pax6Sey/Sey mutant results in a thinner cortical plate that is disproportionately populated 
by deep layer neurons35,37,40–42. As NFIA is more highly expressed in the deep layer neurons as compared 
to upper layer neurons1,3, this could account for the increased NFI protein expression observed within 
this region.
Our findings in this study are supported by previous independent chromatin immunoprecipitation 
experiments suggesting that Nfia and Nfib are not direct targets of PAX6 during neocortical develop-
ment. Chromatin immunoprecipitation for PAX6 using E12.5 neocortical and E15.5 forebrain tissues 
does not detect binding of this transcription factor to the Nfi promoter regions27,43. Interestingly, binding 
of PAX6 at the Nfia and Nfib promoter regions in mice was detected for the pancreatic β T3 cells43 and 
the adult olfactory bulb44, respectively.
Similarly, our study is also supported by the phenotypes observed upon deletion of Nfi in mice, or NFI 
haploinsufficiency in humans as compared to that observed with PAX6 deficiency. For instance, PAX6 
deficiency in humans and mice is associated with microcephaly45–47. In contrast, NFI reduction is impli-
cated in ventriculomegaly and macrocephaly9–12. These opposite phenotypes suggest that if PAX6 were 
to regulate Nfi expression, it would likely function as a transcriptional repressor. However, no increase 
in Nfi expression was observed in the VZ of the Pax6Sey/Sey neocortex by mRNA expression (Fig. 2B) or 
immunohistochemistry analyses (Fig. 3). Taken together, this evidence indicates that PAX6 is not a direct 
regulator of Nfi expression during neocortical development.
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Figure 3. NFI protein expression is not reduced in the ventricular zone of E13 and E15 Pax6Sey/Sey 
neocortex. Representative immunofluorescence images of rostral, middle and caudal cortical regions stained 
for NFIA (A; red) or NFIB (B; red) and co-stained for DAPI (blue) in E13 wildtype (WT) and Pax6Sey/Sey 
mutant (SEY) horizontal brain sections representing the middle of the dorsal telencephalon. Fluorescence 
intensity histograms represent the mean fluorescence intensity of NFIA (A) or NFIB (B) expression, divided 
into 20 equally spaced bins from the ventricular to pial surfaces and normalized to fluorescence intensity 
of DAPI within each bin (n = 6 per genotype). Mean fluorescence intensity for Pax6Sey/Sey is represented in 
red with wildtype in blue. NFIA and NFIB showed no significant change in expression in any of the bins 
that represented the ventricular zone of Pax6Sey/Sey mutants. (C D). Similar analyses were performed using 
E15 Pax6Sey/Sey and wildtype brains sectioned coronally, with matched rostral and caudal sections analyzed 
independently. Similar to E13, NFIA (C) and NFIB (D) expression were not significantly changed in bins 
corresponding to the ventricular zone, but NFI expression was higher in the cortical plate of the Pax6Sey/
Sey mutant. Error bars represent standard error of the mean. VZ = ventricular zone, MZ = marginal zone, 
D = dorsal, M = medial. Scale bar represents 50 μ m.
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While our study demonstrates that down-regulation of expression does not necessarily imply a direct 
transcriptional relationship, similar precautions are required to prevent over-interpretation of our find-
ings. Specifically, binding of PAX6 to the Nfi promoter in pancreatic β T3 cells43 and the adult olfactory 
bulb44 suggest that PAX6 may regulate Nfi expression within other tissue types or perhaps even within 
the neocortex at ages not examined. Interestingly, we note that within our analyses of E13 Nfib heterozy-
gous mice, high expression of both PAX6 and β -galactosidase was present within the hippocampal pri-
mordia (Fig. 2E,F). However, as our analyses were strictly restricted to the developing neocortex, whether 
PAX6 regulates Nfi transcription during hippocampal development necessitates further investigation.
Although we show that PAX6 is not a direct transcriptional activator of Nfi expression in the neocor-
tex, an interesting area of future study would be to determine the mechanism underlying the reduced 
Nfi expression observed in the Pax6Sey/Sey neocortex. We propose an alternative hypothesis for this based 
on previous studies of the Pax6Sey/Sey mutant. As PAX6 is involved in establishing the boundary between 
the dorsal and ventral telencephalon22,48–51, and is required for normal cell cycle exit and cortical cell 
identity specification35,37,40, the reduced Nfi expression observed in the Pax6Sey/Sey mutant may represent 
a change in the cellular composition of the tissue analyzed in gene expression analyses. For example, Nfi 
expression may be indirectly reduced as radial glial cells that lacked functional PAX6 expression may 
differentiate prematurely or transition towards a ventral telencephalic progenitor cell fate22,35,37,40,48–51. 
This in turn results in the thinner cortical plate observed in Pax6Sey/Sey mutants35,37,40–42. As NFIA and 
NFIB are expressed in the VZ and the cortical plate of the developing neocortex, these changes in cellular 
composition may account for the reduced expression of these transcription factors.
To conclude, by analyzing NFI expression in the wildtype and Pax6Sey/Sey neocortices, we determined 
that PAX6 does not directly regulate Nfi expression during neocortical development. Our findings 
demonstrate the importance of careful phenotypic analyses when interpreting transcriptional regulatory 
cascades predicted from mixed cellular populations.
Methods
Animal breeding and tissue collection. All mice used in this study were bred at The University 
of Queensland with approval from the institutional Animal Ethics Committee and all experiments were 
performed in accordance with the approved guidelines. Nfib knockout mice33 and Pax6Sey-neu (referred 
to as Pax6Sey)19 (original breeding stocks were a kind gift from Professor Grant Mastick, University of 
Nevada, Reno) were maintained on the C57Bl/6J and 102/El x C3H/Rl x C57Bl/6J backgrounds respec-
tively. To generate timed-pregnant females, male and female mice were placed together overnight and 
checked the following day for vaginal plugs. This day was designated as E0 if a vaginal plug was pres-
ent. Embryos were removed from dams that were placed under anesthesia using sodium pentobarbi-
tal (Abbott Laboratories), and were either drop fixed (E13 embryos) or transcardially perfused (E15 
embryos) with 0.9% (w/w) saline, followed by 4% (w/w) paraformaldehyde in 1x phosphate-buffered 
saline (PBS; pH 7.4) for further analyses. For mRNA expression analyses of E13 neocortical tissue, the 
dorsolateral cortex (excluding the medial cortex) was microdissected in ice-cold sterile PBS and imme-
diately snap frozen for mRNA isolation.
Immunohistochemistry. Brains of paraformaldehyde-fixed embryos were removed from the skull 
and sectioned coronally, sagittally or horizontally at 50 μ m using a vibratome. Chromogenic immuno-
histochemistry (IHC) or fluorescence immunohistochemistry (IF) was conducted as previously described 
with minor modifications1. Primary antibodies used for immunohistochemistry were as follows: rab-
bit anti-NFIA (1:500; ARP32714, Aviva Systems Biology (IF) or 1:10,000; HPA008884, Sigma (IHC)), 
rabbit anti-NFIB (1:500; ARP32716, Aviva Systems Biology or 1:10,000; HPA003956, Sigma), chicken 
anti-β -galactosidase (1:500; ab9361, Abcam (IF)) and rabbit anti-PAX6 (1:500; ab2237, Abcam (IF)). 
For IHC, a biotinylated goat anti-rabbit secondary antibody (1:500; BA-5000, Vector Laboratories) was 
used, followed by incubation with the VECTASTAIN elite ABC kit (Vector Laboratories) and nickel 
DAB staining as previously described1. For IF, Alexa Fluor 488-conjugated goat anti-chicken (1:500; 
A-11039, Invitrogen) and Alexa Fluor 555-conjugated goat anti-rabbit (1:500; A-11034, Invitrogen) 
secondary antibodies were used for detection. Immunofluorescent sections were counterstained with 
4`,6-diamidino-2-phenylindole, dihydrochloride (DAPI, Invitrogen) to label cell nuclei and covers-
lipped using ProLong Gold anti-fade reagent (Invitrogen). To minimize variability for IF quantification, 
matched sections that were to be compared between Pax6Sey/Sey and wildtype littermates were mounted 
on the same slide to ensure identical staining conditions.
Imaging and data analysis. Brightfield and wide-field fluorescence imaging was performed with a 
Zeiss upright Axio-Imager Z1 microscope fitted with Axio- Cam HRc and HRm cameras and Apotome. 
Images were acquired with AxioVision software (Carl Zeiss) or ZEN blue (Carl Zeiss). For IF, matched 
sections from 6 brains were imaged per condition using identical acquisition settings to allow for quanti-
fication. Following this, matched neocortical regions of 100 μ m width were cropped from each section in 
Photoshop (Adobe) and imported into ImageJ software (NIH). To generate fluorescence intensity histo-
grams, cropped sections were divided into 20 bins of equal size across the ventricular to pial surfaces and 
fluorescence intensity corresponding to NFIA or NFIB was normalized to DAPI intensity within each 
bin. Statistical significance was determined using one-way ANOVA, with p-values below 0.05 considered 
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significant. All values are presented as the mean, with error bars representing the standard error of the 
mean. Images in figures are representative images that have been identically cropped, enhanced for con-
trast and brightness, and pseudo-colored to permit overlay using Adobe Photoshop software.
Quantification of Nfi mRNA expression. Quantitative PCR was performed as previously 
described52. Briefly, RNA of snap-frozen E13 neocortex of Pax6Sey mutant or wildtype littermates of 3 
litters was isolated using TRIzol reagent (Invitrogen) and 1 μ g of RNA was reverse transcribed using 
SuperScript III First-Strand Synthesis SuperMix (Invitrogen) and Oligo(dT) primers (Invitrogen) as per 
the manufacturer’s instructions. Diluted samples were used for real-time qPCR with Platinum SYBR 
Green qPCR SuperMix (Invitrogen) and 0.25 μ M forward and reverse primers. The qPCR reaction was 
carried out on a Rotor-Gene 3000 (Corbett Life Science) with the following thermocycler conditions: 
10 minutes at 95 °C followed by 40 cycles with 15 seconds denaturation at 95 °C, 20 seconds annealing at 
60 °C, and 30 seconds extension at 72 °C. Relative expression was determined using the Δ Δ Ct method 
with the housekeeping gene beta-2-microglobulin used as a relative standard. Statistical analyses were 
performed using one-way ANOVA. Error bars represent the standard error of the mean. Primers were 
as previously described28: B2MM 5`-agactgatacatacgcctgcag-3`, B2MMC 5`-gcaggttcaaatgaatcttcag-3`, 
mNFI-AE23 5`-ggcatactttgtacatgcagc-3`, mNFI-AE4C2 5`-acctgatgtgacaaagctgtcc-3`, mNFI-BE2 
5`-gtttttggcatactacgtgcagg-3` and mNFI-BE3C 5`-ctctgatacattgaagactccg-3`.
Dual-luciferase reporter assays. The U251 MG human glioblastoma53 and NE-4C mouse neu-
roepithelial54 cell lines were obtained from American Type Culture Collection (ATCC) and cultured 
in DMEM medium (Invitrogen), supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 
100 μ g/mL streptomycin (Invitrogen) at 37 °C in a humidified atmosphere containing 5% CO2. The 
mouse Nfia (2,329 base pairs) and Nfib (2,484 base pairs) promoters were cloned into the pGL4.23 
luciferase construct (Promega) to drive firefly luciferase expression, using primers with added NheI 
(forward primer) and BglII (reverse primer) restrictions sites; pNfia_F 5`-ttacatgttggttccctcagc-3`, pNfi-
a_R 5`-tgcttacctgggtgagacag-3` pNfib_F 5`-ccaggctcttggtttacagg-3`, pNfib_R 5`-tcgccttaaaacgcactttc-3’. 
The mouse PAX6 coding sequence was cloned into pCAGIG (Addgene) from pMXIG-Pax655, kindly 
provided by Professor Magdalena Gotz. Cells were seeded into a 96-well plate 24 hours prior to trans-
fection at a density of 3,000 cells per well. pNfia-Luc, pNfib-Luc or the control pGL4.23 plasmid were 
co-transfected with either pCAGIG-PAX6 or pCAGIG into seeded cells using FuGENE HD (Promega). 
Renilla luciferase (pRL-SV40, Promega) was co-transfected with all transfections as an internal control 
for normalization of firefly luciferase activity. Luciferase activity was assayed 48 hours after transfection 
using the Dual-Luciferase Reporter Assay System (Promega). All experimental conditions were per-
formed as three independent experiments of triplicates, of which one is represented. Statistical signifi-
cance was determined using a one-way ANOVA.
Microarray expression data analysis. Expression data of Pax6Sey mutant E12.5 neocortical radial 
glial cells (GSE38703)34, Pax6Sey, Pax6Leca2 and Pax6Leca4 mutant E14 rostral cortex (GSE35260)29 and 
Pax6Sey mutant E14.5 neocortex (GSE32271)30 were obtained from the Gene Expression Omnibus data-
base. The processed data in 2log scale were converted to absolute scale and the difference in expression 
of Nfia or Nfib as compared to the wildtype embryos was calculated and represented as a percentage of 
the expression in wildtype controls. When more than 3 samples were available, statistical significance was 
determined using one-way ANOVA. Expression in human cortex at 12 and 13 weeks post-conception 
was obtained from the GSE25219 dataset24 and analyzed and visualized using the R2: microarray analysis 
and visualization platform (http://r2.amc.nl) as previously described56.
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